Long noncoding RNA polymorphisms and hepatocellular carcinoma and pancreatic cancer risk

被引：3
作者：
Abdi, Esmat [1 ]
Latifi-Navid, Saeid [1 ]
机构：
[1] Univ Mohaghegh Ardabili, Dept Biol, Ardebil 5619911367, Iran
来源：
PERSONALIZED MEDICINE | 2023年 / 20卷 / 02期
关键词：
cancer risk; hepatocellular carcinoma; lncRNA polymorphisms; pancreatic cancer; ASSOCIATION; MECHANISMS; GENES; GAS5;
D O I：
10.2217/pme-2021-0156
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Hepatocellular carcinoma (HCC) and pancreatic cancer (PC) are among serious malignancies with no proper biomarker suffering from poor prognosis and late onset. Regulation of long noncoding RNAs (lncRNAs) is disturbed in tumors, making them appropriate diagnostic markers or therapeutic targets in systemic therapies. The expression and function of some significant lncRNAs are under the influence of SNPs, highlighting their key role in carcinogenesis. This review assesses the associations between SNPs in lncRNAs and HCC and PC risk. A panel of cancer-associated SNPs in lncRNA genes could help evaluate the clinical use of lncRNAs, including their role as diagnostic markers and therapeutic targets. Nonetheless, more large-scale surveys on various ethnic groups are required to validate results.
引用
收藏
页码：193 / 200
页数：8
相关论文
共 47 条
  • [21] On the classification of long non-coding RNAs
    Ma, Lina
    Bajic, Vladimir B.
    Zhang, Zhang
    [J]. RNA BIOLOGY, 2013, 10 (06) : 925 - 934
  • [22] Long Noncoding RNA MALAT1 Promotes Hepatocellular Carcinoma Development by SRSF1 Upregulation and mTOR Activation
    Malakar, Pushkar
    Shilo, Asaf
    Mogilevsky, Adi
    Stein, Ilan
    Pikarsky, Eli
    Nevo, Yuval
    Benyamini, Hadar
    Elgavish, Sharona
    Zong, Xinying
    Prasanth, Kannanganattu V.
    Karni, Rotem
    [J]. CANCER RESEARCH, 2017, 77 (05) : 1155 - 1167
  • [23] Mazzanti Roberto, 2016, World J Exp Med, V6, P21, DOI 10.5493/wjem.v6.i1.21
  • [24] Minotti L., 2018, HIGH THROUGHPUT, V7, P1
  • [25] Minotti Linda, 2018, High Throughput, V7, DOI 10.3390/ht7040034
  • [26] Moschovis D, 2019, CANCER BIOMARK, V24, P117, DOI [10.3233/cbm-181959, 10.3233/CBM-181959]
  • [27] The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients
    Motawi, Tarek M. K.
    El-Maraghy, Shohda A.
    Sabry, Dina
    Mehana, Noha A.
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (09) : 14645 - 14656
  • [28] Long noncoding RNA HULC is a novel biomarker of poor prognosis in patients with pancreatic cancer
    Peng, Wei
    Gao, Wei
    Feng, Jifeng
    [J]. MEDICAL ONCOLOGY, 2014, 31 (12) : 1 - 7
  • [29] Molecular and Cellular Mechanisms of Action of Tumour Suppressor GAS5 LncRNA
    Pickard, Mark R.
    Williams, Gwyn T.
    [J]. GENES, 2015, 6 (03): : 484 - 499
  • [30] The H19 Long non-coding RNA in cancer initiation, progression and metastasis - a proposed unifying theory
    Raveh, Eli
    Matouk, Imad J.
    Gilon, Michal
    Hochberg, Abraham
    [J]. MOLECULAR CANCER, 2015, 14
12345